单选题
题号 #6528567

The Global Challenges Research Fund is cited as an example to

进入在线模考

参考答案

D

答案解析

[信息锁定]第五段①句指出,当前政府对科技的看法相比之前政府的态度“将科学视为应对全球挑战的外交工具以及促进竞争的手段”发生了转变(a shift)。②句举例指出,“全球挑战研究基金”的设立意在加强国际合作,实现联合国可持续发展目标。③句则指出现在这种精神已经被一种意在保护国家免受威胁以及表现英国硬实力的情绪所取代。联系三句推知,作者举例意在说明政府看待科学的态度变化,D项正确。
[解题技巧]A项将第五段①句“政府对于科学的态度转变”(a shift from the approach of previousgovernments)偷换为与之完全不同的“科学研究方法的转变”(shift in research approaches)。B项利用第五段关键词global challenges设置于扰.但文中并未提及应对全球挑战的紧迫性,urgency一词无中生有。C项利用第五段③句关键词the United Kingdom’S hard power设置干扰,但这是在说明当前英国政府的态度“发展科技以展现英国硬实力”,并非作者举例“全球挑战研究基金”的目的。

你可能感兴趣的试题

A.ARIA Should Let the Sunshine In
A.ARIA Should Let the Sunshine In
B.FoI Laws Are Becoming Outdated
B.FoI Laws Are Becoming Outdated
C.High-risk: Not Necessarily High-reward
C.High-risk: Not Necessarily High-reward
D.Peer Review: An Obstacle to Creativity
D.Peer Review: An Obstacle to Creativity
2 根据以下材料,回答题
Patents are supposed to incentivize success.And yet that's not how patent law works today.The courts, Congress and boardrooms are advancing a simple logic that turns the patent system onits head.The consequences are on display in the pharmaceutical industry.For example, a Johnson& Johnson report argues that the cost of a drug should not only reflect research costs related to thatdrug, but also should include expenses from "drug candidates that fail in development".
  But the patent system is designed to reward success.One does not receive a patent for aninvention one tried and failed to create.Similarly, a patent's reward reflects the successfulinvention, rather than compensation for other attempts gone bad.
  Ensuring that rewards cover the costs of failure might appear logical at first glance.Butallowing the patent system to compensate for the cost of failures has a perverse effect, particularlywhen the pharmaceutical industry uses it to lobby for expansion of patent protection.The argumenthas become: We need to hold off competition more, so that we can charge more to compensate forpast failures.But that distorts the purpose of a patent.If patents reward failure, then the more acompany fails, the longer and broader of a monopoly they'll need when they do succeed.
  In a perfect world, one might expect purchasers to create a natural brake on the system.Intheory, one cannot charge a price unless buyers are willing to pay.Health care is a strange market,however.Patients may consume the medication, but doctors are in charge of choosing it, andinsurance pays for much of it.In addition, modem strategic behaviors in the drug approval andreimbursement system can diminish the competition that might otherwise prevent drug companiesfrom raising prices unchallenged.Thus, the normal pressures that would limit prices are dampenedin the market for prescription medicine.
  Incentivizing failure is particularly problematic in light of a historic shift in the pharmaceuticalindustry over the past decade.Faced with stagnating research results, the industry has shifted tooutsourcing innovation.Specifically, the majority of innovation in the industry comes fromacademia or from small life-science companies.Large pharmaceutical companies then shepherd thedrugs through the FDA approval process and into production.And so, at the end of the day, thebig companies--the ones arguing for compensation for failure through hefty patent returns--are notthe ones taking the greatest risks for drug development.Rather, they are gaming the patent system:maintaining high prices and keeping competitors out with patent protections.
  If society actually wanted a patent system that compensates for failure, the dollars would go tothose who make the investment in the research and take the risk of failure--the inventors.None ofthat is happening here.Instead, by passing so little of the profit to those who perform the successfulresearch, the system dilutes the incentive for research.We are not just incentivizing failure, we aresending those dollars to the least inventive part of the innovation chain.
The Johnson & Johnson report is cited to show that
A.a successful drug innovation is built on many failed attempts.
B. a pharmaceutical company needs to invest hugely in research.
C. the existing patent law is unsuitable for the current reality.
D.the patent system has failed to serve its intended purpose.
A. supportive.
B.  tolerant.
C. sarcastic.
D.  confused.
找试题 · 找答案 · 找资料 在线模考